HIMS logo

Hims & Hers Health (HIMS) EBITDA

annual EBITDA:

$78.99M+$98.93M(+496.18%)
December 31, 2024

Summary

  • As of today (June 21, 2025), HIMS annual EBITDA is $78.99 million, with the most recent change of +$98.93 million (+496.18%) on December 31, 2024.
  • During the last 3 years, HIMS annual EBITDA has risen by +$189.96 million (+171.18%).
  • HIMS annual EBITDA is now at all-time high.

Performance

1-year change

+496.18%

3-year change

+171.18%

5-year change

+210.72%

15-year change

+210.72%

HIMS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

53.49%
HIMS annual EBITDA is higher than 53.49% of companies in Consumer Defensive sector

Range

All-time high

$78.99M
HIMS annual EBITDA is currently at an all-time high

3-year low

-$110.97M

Earnings dates

Last annual earnings report date

Dec 31, 2024
HIMS previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
HIMS next annual earnings announcement has not yet been scheduled

OtherHIMSincome statement metrics

Annual revenue

$1.48B
HIMS annual revenue is $1.48 billion

annual net income

$126.04M
HIMS annual net profit is $126.04 million

annual EBIT

$61.90M
HIMS annual earnings before interest & taxes is $61.90 million

Annual EPS

$0.53
HIMS annual earnings per share is $0.53

quarterly EBITDA:

$66.17M+$41.52M(+168.37%)
March 31, 2025

Summary

  • As of today (June 21, 2025), HIMS quarterly EBITDA is $66.17 million, with the most recent change of +$41.52 million (+168.37%) on March 31, 2025.
  • Over the past year, HIMS quarterly EBITDA has increased by +$53.27 million (+412.81%).
  • HIMS quarterly EBITDA is now at all-time high.

Performance

3-month change

+168.37%

1-year change

+412.81%

3-year change

+535.98%

5-year change

+1239.34%

HIMS quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

64.25%
HIMS quarterly EBITDA is higher than 64.25% of companies in Consumer Defensive sector

Range

All-time high

$66.17M
HIMS quarterly EBITDA is currently at an all-time high

3-year low

-$18.37M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
HIMS previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 5, 2025
HIMS next earnings announcement is scheduled for Aug 5, 2025

OtherHIMSincome statement metrics

Quarterly revenue

$586.01M
HIMS quarterly revenue is $586.01 million

quarterly net income

$49.48M
HIMS quarterly net profit is $49.48 million

quarterly EBIT

$57.90M
HIMS quarterly earnings before interest & taxes is $57.90 million

Quarterly EPS

$0.20
HIMS quarterly earnings per share is $0.20

TTM EBITDA:

$132.26M+$53.27M(+67.44%)
March 31, 2025

Summary

  • As of today (June 21, 2025), HIMS TTM EBITDA is $132.26 million, with the most recent change of +$53.27 million (+67.44%) on March 31, 2025.
  • Over the past year, HIMS TTM EBITDA has increased by +$130.15 million (+6162.31%).
  • HIMS TTM EBITDA is now at all-time high.

Performance

3-month change

+67.44%

1-year change

+6162.31%

3-year change

+269.28%

5-year change

+836.5%

HIMS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

51.13%
HIMS TTM EBITDA is higher than 51.13% of companies in Consumer Defensive sector

Range

All-time high

$132.26M
HIMS TTM EBITDA is currently at an all-time high

3-year low

-$79.60M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
HIMS previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 5, 2025
HIMS next earnings announcement is scheduled for Aug 5, 2025

OtherHIMSincome statement metrics

TTM revenue

$1.78B
HIMS TTM revenue is $1.78 billion

TTM net income

$164.40M
HIMS TTM net profit is $164.40 million

TTM EBIT

$109.90M
HIMS TTM earnings before interest & taxes is $109.90 million

TTM EPS

$0.69
HIMS TTM earnings per share is $0.69

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

$78.99M
HIMS annual EBITDA is $78.99 million

annual net income

$126.04M
HIMS annual net profit is $126.04 million

annual interest expense

-
HIMS annual interest expense value is unknown

annual income tax

-$54.33M
HIMS annual income tax is -$54.33 million

annual D&A

$17.09M
HIMS annual depreciation & amortization is $17.09 million

HIMS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+496.2%+412.8%+6162.3%
3 y3 years+171.2%+536.0%+269.3%
5 y5 years+210.7%+1239.3%+836.5%

HIMS EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+171.2%at high+460.2%at high+266.2%
5 y5-yearat high+171.2%at high+237.8%at high+219.2%
alltimeall timeat high+171.2%at high+237.8%at high+219.2%

HIMS EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$66.17M(+168.4%)
$132.26M(+67.4%)
Dec 2024
$78.99M(-496.2%)
$24.66M(-7.8%)
$78.99M(+39.6%)
Sep 2024
-
$26.76M(+82.4%)
$56.59M(+139.4%)
Jun 2024
-
$14.67M(+13.7%)
$23.64M(+1019.5%)
Mar 2024
-
$12.90M(+471.5%)
$2.11M(-110.6%)
Dec 2023
-$19.94M(-67.4%)
$2.26M(-136.5%)
-$19.94M(-37.3%)
Sep 2023
-
-$6.19M(-9.7%)
-$31.79M(-27.2%)
Jun 2023
-
-$6.86M(-25.0%)
-$43.68M(-20.9%)
Mar 2023
-
-$9.15M(-4.7%)
-$55.19M(-9.9%)
Dec 2022
-$61.22M
-$9.60M(-46.9%)
-$61.22M(-14.4%)
Sep 2022
-
-$18.08M(-1.6%)
-$71.56M(-10.1%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$18.37M(+21.0%)
-$79.60M(+1.9%)
Mar 2022
-
-$15.18M(-23.9%)
-$78.13M(-29.6%)
Dec 2021
-$110.97M(+687.7%)
-$19.93M(-23.7%)
-$110.97M(+19.3%)
Sep 2021
-
-$26.11M(+54.5%)
-$93.04M(+28.4%)
Jun 2021
-
-$16.90M(-64.8%)
-$72.46M(+28.7%)
Mar 2021
-
-$48.02M(+2292.4%)
-$56.29M(+299.6%)
Dec 2020
-$14.09M(-80.3%)
-$2.01M(-63.8%)
-$14.09M(-41.9%)
Sep 2020
-
-$5.54M(+656.8%)
-$24.23M(+29.6%)
Jun 2020
-
-$732.00K(-87.4%)
-$18.69M(+4.1%)
Mar 2020
-
-$5.81M(-52.2%)
-$17.96M(+47.8%)
Dec 2019
-$71.34M
-$12.15M
-$12.15M

FAQ

  • What is Hims & Hers Health annual EBITDA?
  • What is the all time high annual EBITDA for Hims & Hers Health?
  • What is Hims & Hers Health annual EBITDA year-on-year change?
  • What is Hims & Hers Health quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Hims & Hers Health?
  • What is Hims & Hers Health quarterly EBITDA year-on-year change?
  • What is Hims & Hers Health TTM EBITDA?
  • What is the all time high TTM EBITDA for Hims & Hers Health?
  • What is Hims & Hers Health TTM EBITDA year-on-year change?

What is Hims & Hers Health annual EBITDA?

The current annual EBITDA of HIMS is $78.99M

What is the all time high annual EBITDA for Hims & Hers Health?

Hims & Hers Health all-time high annual EBITDA is $78.99M

What is Hims & Hers Health annual EBITDA year-on-year change?

Over the past year, HIMS annual EBITDA has changed by +$98.93M (+496.18%)

What is Hims & Hers Health quarterly EBITDA?

The current quarterly EBITDA of HIMS is $66.17M

What is the all time high quarterly EBITDA for Hims & Hers Health?

Hims & Hers Health all-time high quarterly EBITDA is $66.17M

What is Hims & Hers Health quarterly EBITDA year-on-year change?

Over the past year, HIMS quarterly EBITDA has changed by +$53.27M (+412.81%)

What is Hims & Hers Health TTM EBITDA?

The current TTM EBITDA of HIMS is $132.26M

What is the all time high TTM EBITDA for Hims & Hers Health?

Hims & Hers Health all-time high TTM EBITDA is $132.26M

What is Hims & Hers Health TTM EBITDA year-on-year change?

Over the past year, HIMS TTM EBITDA has changed by +$130.15M (+6162.31%)
On this page